Biomica’s CEO, Dr. Elran Haber, is heading to Brussels this week for the Microbiome Times Partnering Forum – a key event for advancing microbiome-based therapeutics through strategic partnerships. More info & registration: www.microbiomeforum.com
Dr. Elran Haber, Biomica’s CEO, will attend MIXiii Health-Tech.IL 2025 on March 4-5 at ICC Jerusalem. This leading Israeli health-tech conference unites industry leaders, startups, and investors to explore innovations in personalized medicine, AI-driven drug development, cancer treatment, and more. More info & registration: www.mixiii.com
We’re excited to join Startup Nation Central’s Israel Health Tech delegation to the U.S. Our CEO, Dr. Elran Haber, will proudly represent Biomica on this journey.
Dr. Elran Haber, CEO of Biomica will be attending Biotech Showcase 2025 as part of the J.P. Morgan Annual Healthcare week in San Francisco. If you’d like to meet with Dr. Haber, please get in touch through the partnering platform or DM us.
Biomica was delighted to host an inspiring investor meeting and workshop in Hong Kong, bringing together leading academics, local investors, researchers, and partners. Dr. Elran Haber, Biomica’s CEO, presented the company’s cutting-edge advancements in microbiome-based therapeutics, while Prof. Gal Markel shared his insights into the recent positive Ph1 results and the transformative potential of these […]
Biomica’s CEO, Dr. Elran Haber, will be a featured panelist at the Microbiome Connect USA event on Wednesday, November 20, at 9:30 AM (local time). Join him for the session: “Taking the Bird’s Eye View: Market Insights & Dynamics of Microbiome Drug Development”.
Biomica’s Chief Scientific Officer, Prof. Yehuda Ringel, will present at FNM 2024 in the session “Abdominal Pain from Bench to Bedside” on November 8. We look forward to sharing how our microbiome research is advancing gastrointestinal health. For more information, visit the conference website: https://www.fnm2024.com/
Biomica will be attending Bio Europe conference, and we’re looking forward to connecting with industry leaders and innovators. Our CEO, Dr. Elran Haber, and VP of Business Development, Mel Larrosa, will be available for meetings.
Dr. Elran Haber, CEO of Biomica, will be participating as a panelist at the 9th Microbiome Movement – Drug Development Summit. On July 12th at 9:30 am ET, Dr. Haber will engage in the panel discussion “Defining Innovative Clinical Strategies Conserving Spend.” This discussion will explore adaptive trial methodologies, strategic partnerships, and criteria for attracting […]
